Longitudinal treatment outcomes of recurrent clival chordomas: a single-center retrospective study

CONCLUSIONS: Despite the aggressive nature of recurrent chordoma, 14 of 29 patients (48%) survived for more than 5 years after the initial recurrence using combined therapies. Multiple treatment options may contribute to the long-term survival of patients with this intractable tumor.PMID:37856417 | DOI:10.3171/2023.7.JNS231196

Source: Journal of Neurosurgery - October 19, 2023 Category: Neurosurgery Authors: Sukwoo Hong Anita Mahajan Yuki Shinya Nadia N Laack Michael J Link Erin K O'Brien Janalee K Stokken Jeffrey R Janus Thanh P Ho Garret Choby Jamie J Van Gompel Source Type: research